Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVM
3401
Silvercorp Metals
SVM
$2.07B
| $102K | ﹤0.01% |
36,050
+28,350
| +368% | +$96.4K |
|
3402
Alliance Resource Partners
ARLP
$3.34B
| $102K | ﹤0.01% |
5,497
+4,413
| +407% | +$84.6K |
|
3403
Compass Therapeutics
CMPX
$344M
| $102K | ﹤0.01% |
31,921
-9,065
| -22% | -$28.5K |
|
3404
Citizens
CIA
$239M
| $101K | ﹤0.01% |
42,112
| – | – |
|
3405
Aveanna Healthcare
AVAH
$2.04B
| $101K | ﹤0.01% |
60,036
-12,910
| -18% | -$16.2K |
|
3406
Ardmore Shipping
ASC
$710M
| $101K | ﹤0.01% |
8,194
-12,573
| -61% | -$168K |
|
|
BZUN
3407
Baozun
BZUN
$167M
| $101K | ﹤0.01% |
25,321
-57,017
| -69% | -$255K |
|
3408
Eos Energy Enterprises
EOSE
$1.22B
| $100K | ﹤0.01% |
23,134
-245,307
| -91% | -$644K |
|
3409
Bassett Furniture
BSET
$164M
| $100K | ﹤0.01% |
6,665
| – | – |
|
|
EXK
3410
Endeavour Silver
EXK
$2.23B
| $99.9K | ﹤0.01% |
+34,572
| New | +$122K |
|
3411
BlackSky Technology
BKSY
$943M
| $99.8K | ﹤0.01% |
5,618
-5,136
| -48% | -$61.4K |
|
3412
Design Therapeutics
DSGN
$761M
| $99.7K | ﹤0.01% |
15,820
-1,397
| -8% | -$8.55K |
|
3413
iShares MSCI KLD 400 Social ETF
DSI
$5.3B
| $99.2K | ﹤0.01% |
+1,179
| New | +$93.7K |
|
3414
KB Financial Group
KB
$41.4B
| $99.1K | ﹤0.01% |
2,722
| – | – |
|
3415
Alto Ingredients
ALTO
$369M
| $99K | ﹤0.01% |
34,253
-36,124
| -51% | -$68.8K |
|
3416
Five Star Bancorp
FSBC
$1.14B
| $98.5K | ﹤0.01% |
4,405
-1,983
| -31% | -$40.3K |
|
|
ABST
3417
DELISTED
Absolute Software Corp
ABST
| $98.5K | ﹤0.01% |
8,594
+7,972
| +1,282% | +$79.8K |
|
3418
eHealth
EHTH
$42.2M
| $98.4K | ﹤0.01% |
12,235
-8,672
| -41% | -$69.3K |
|
3419
Cellebrite
CLBT
$3.68B
| $98.1K | ﹤0.01% |
+13,626
| New | +$79.4K |
|
3420
Entrada Therapeutics
TRDA
$264M
| $97.5K | ﹤0.01% |
6,440
-3,788
| -37% | -$52.2K |
|
|
DSKE
3421
DELISTED
Daseke, Inc. Common Stock
DSKE
| $96.4K | ﹤0.01% |
13,527
-6,825
| -34% | -$47.9K |
|
3422
Clarus
CLAR
$123M
| $96.1K | ﹤0.01% |
10,515
-4,046
| -28% | -$35.7K |
|
3423
Richardson Electronics
RELL
$267M
| $96K | ﹤0.01% |
5,817
-14,544
| -71% | -$251K |
|
|
GBIO
3424
DELISTED
Generation Bio
GBIO
| $95.7K | ﹤0.01% |
1,740
-1,279
| -42% | -$58.7K |
|
3425
Toyota
TM
$224B
| $95.2K | ﹤0.01% |
592
| – | – |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.